Status and phase
Conditions
Treatments
About
This is a Phase I trial to evaluate the safety and immunogenicity of a ChAdOx1 85A vaccination with and without MVA85A boost in healthy BCG vaccinated adults.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Subjects must meet all of the following criteria to enter the trial:
Exclusion criteria
Subjects must meet none of the following criteria to enter the trial:
Primary purpose
Allocation
Interventional model
Masking
42 participants in 4 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal